[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

September 2020 | 150 pages | ID: M27F7ACD3B2EEN
OG Analysis

US$ 4,580.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The study predicts the short term and long term trends that can shape up the future of the Molecular Diagnostics market including the COVID-19 pandemic implications for Molecular Diagnosticss industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Molecular Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Molecular Diagnostics Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Molecular Diagnostics market forecast and Molecular Diagnostics market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Molecular Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Molecular Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Molecular Diagnostics market share in developed countries.

Scope of the research-

Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 By Product including
Reagents & Kits 
Instruments 
Services & Software

Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 by technology including
Polymerase Chain Reaction (PCR) 
Isothermal Nucleic Acid Amplification Technology (INAAT) 
DNA Sequencing & Next-Generation Sequencing (NGS) 
in Situ Hybridization 
DNA Microarray 
Cultural

Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Infectious Diseases 
Hepatitis
HIV
CT/NG
HAIS
HPV
Tuberculosis
Influenza
Other Infectious Diseases
Oncology 
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Genetic Tests 
Other Applications

Top Companies Operating in Molecular Diagnostics market include- Abbott Laboratories  , Agilent Technologies  , Becton, Dickinson and Company  , Biom?rieux Sa  , Danaher Corporation  , Diasorin  , Grifols  , Hologic  , Illumina  , Qiagen 
1. TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2. EXECUTIVE SUMMARY

2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Molecular Diagnostics Market- Key Findings, 2020

3. STRATEGIC IMPERATIVES ON GLOBAL MOLECULAR DIAGNOSTICS MARKET

3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Molecular Diagnostics Companies

4. MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026, BY PRODUCT

4.1 Reagents & Kits
4.2 Instruments
4.3 Services & Software

5. MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026, BY TECHNOLOGY

5.1 Polymerase Chain Reaction (PCR)
5.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3 DNA Sequencing & Next-Generation Sequencing (NGS)
5.4 in Situ Hybridization
5.5 DNA Microarray
5.3 Cultural

6. MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026, BY APPLICATION

6.1 Infectious Diseases
  6.1.1 Hepatitis
  6.1.2 HIV
  6.1.3 CT/NG
  6.1.4 HAIS
  6.1.5 HPV
  6.1.6 Tuberculosis
  6.1.7 Influenza
  6.1.8 Other Infectious Diseases
6.2 Oncology
  6.2.1 Breast Cancer
  6.2.2 Colorectal Cancer
  6.2.3 Lung Cancer
  6.2.4 Prostate Cancer
  6.2.5 Other Cancers
6.3 Genetic Tests
6.4 Other Applications

7 ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026

7.1 Leading Molecular Diagnostics Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Molecular Diagnostics
7.3 Top countries contributing to Asia Pacific Molecular Diagnostics

8 EUROPE MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026

8.1 Leading Molecular Diagnostics Types contributing to Europe market
8.2 Top Applications contributing to Europe Molecular Diagnostics
8.3 Top countries contributing to Europe Molecular Diagnostics

9 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026

9.1 Leading Molecular Diagnostics Types contributing to North America market
9.2 Top Applications contributing to North America Molecular Diagnostics
9.3 Top countries contributing to North America Molecular Diagnostics

10 SOUTH AND CENTRAL AMERICA MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026

10.1 Leading Molecular Diagnostics Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Molecular Diagnostics
10.3 Top countries contributing to South and Central America Molecular Diagnostics

11 MIDDLE EAST AFRICA MOLECULAR DIAGNOSTICS MARKET VALUE OUTLOOK TO 2026

11.1 Leading Molecular Diagnostics Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Molecular Diagnostics
11.3 Top countries contributing to Middle East Africa Molecular Diagnostics

12 BUSINESS PROFILES OF LEADING COMPANIES

12.1 Business Description, SWOT and Financial Analysis of Companies in Molecular Diagnostics market
12.2 Abbott Laboratories
12.3 Agilent Technologies
12.4 Becton, Dickinson and Company
12.5 Biom?rieux Sa
12.6 Danaher Corporation
12.7 Diasorin
12.8 Grifols
12.9 Hologic
12.10 Illumina
12.11 Qiagen

13 RECENT INDUSTRY DEVELOPMENTS

14 APPENDIX

14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts


More Publications